1. Home
  2. CLSK vs TLX Comparison

CLSK vs TLX Comparison

Compare CLSK & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CleanSpark Inc.

CLSK

CleanSpark Inc.

HOLD

Current Price

$11.27

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$10.68

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLSK
TLX
Founded
1987
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.2B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CLSK
TLX
Price
$11.27
$10.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
4
Target Price
$19.44
$21.13
AVG Volume (30 Days)
17.4M
210.3K
Earning Date
05-07-2026
04-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$766,314,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.89
N/A
P/E Ratio
N/A
$150.33
Revenue Growth
102.21
N/A
52 Week Low
$7.03
$6.28
52 Week High
$23.61
$19.93

Technical Indicators

Market Signals
Indicator
CLSK
TLX
Relative Strength Index (RSI) 63.98 69.19
Support Level $8.78 $10.60
Resistance Level $14.04 $11.18
Average True Range (ATR) 0.70 0.32
MACD 0.27 0.14
Stochastic Oscillator 84.11 70.36

Price Performance

Historical Comparison
CLSK
TLX

About CLSK CleanSpark Inc.

Cleanspark Inc. is a data center developer that, until recently, focused exclusively on bitcoin mining. The company provides scalable, energy-efficient digital infrastructure across the United States. The Company has a sole reporting segment, which is the bitcoin mining segment.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: